# 2026-10-06 WeChat transport/readback review — scope-complete WYSIWYG

Status: **PASS**

Final WeChat publisher result:
- stage: `draft_update`
- paper_count: `29`
- article_count: `2`
- draft_readback: `ok`
- media_id: `KhELYUzvwADwB_l1xH1SWFv31tB1FbKXF89D7ZHLK2znutU4BOGt5XD22WOo65yQ`
- receipt time: `2026-10-06T07:44:44.054726Z`
- preview: https://relay.gczhouwld.com/wechat-preview/6042550fb27bf3726eea84b7.html

## Readback decision

The final fixed-IP publisher run completed successfully and immediately read the same draft back through WeChat `draft/get`.

The source fingerprints used for this write still match the passed gate:
- daily Nature Chemistry manifest: `cb172b559f3b63f6ee64d6f26a74cbd31eeffe5f`
- Hyster retrospective manifest: `7979c88174aac3318e5f77d8bbaf3f44a2d5044c`

The gate also pins every production raster by Git blob SHA. No body figure is produced by runtime fractional cropping.

## Final content state

### Nature Chemistry
- no isolated Fig. 1c opening image;
- Fig. 1e appears after the text that explains the failure modes / alternating-polarity role;
- redox speciation, electrochemical evidence, electrode behaviour and mechanism each have their own reviewed figure;
- Fig. 4a substrate/feedstock scope is now a dedicated section;
- Fig. 4b synthetic diversification / downstream coupling is now a dedicated section;
- limitations remain after the scope/application discussion.

### Nature / Hyster
- exact user-confirmed blue FRET/PLP* cover retained;
- complete Fig. 1c overview retained;
- directed evolution is shown before deeper mechanism;
- Fig. 3 scope is split into readable pyrimidine and pyridine blocks;
- external FRET, intra-enzyme FRET, radical mechanism, lifetime evidence and Lenacapavir application are each represented by separate reviewed visuals;
- peer-review caveats and current limitations remain explicit.

## Final decision

**PASS — the current WeChat draft is the reviewed scope-complete, WYSIWYG version.**

No TinyFish dependency was used for the final approval path.
